SCHEMBL13531815

SCHEMBL13531815

COc1ccc2c(c1)CCCN2S(C)(=O)=O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.66
KMT2A Q03164 1/20 0.66
TP53 P04637 4/20 0.59
NLRP3 Q96P20 1/20 0.59
HSD17B10 Q99714 1/20 0.58
TSHR P16473 1/20 0.56
MCOLN3 Q8TDD5 1/20 0.56
CDC25A P30304 1/20 0.53
CDC25B P30305 1/20 0.53
CDC25C P30307 1/20 0.53
DUSP3 P51452 1/20 0.53
RAB9A P51151 1/20 0.53
MAPT P10636 2/20 0.52
NOTUM Q6P988 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA9 Q16790 1/20 0.51
CA14 Q9ULX7 1/20 0.51
CYP11B1 P15538 3/20 0.51
CYP11B2 P19099 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12940032 0.90 NLRP3 (0.68) MEN1KMT2ATP53NLRP3HSD17B10
SCHEMBL3180468 0.87 MEN1 (0.51) MEN1KMT2ATP53NLRP3HSD17B10
SCHEMBL31190148 0.83 KMT2A (0.60) MEN1KMT2ATP53NLRP3HSD17B10
SCHEMBL3192299 0.82 HPGD (0.49) MEN1KMT2ATP53NLRP3CDC25A
SCHEMBL10066942 0.81 TP53 (0.57) MEN1KMT2ATP53RAB9AMAPT
SCHEMBL3182062 0.80 TP53 (0.55) MEN1KMT2ATP53RAB9AMAPT
SCHEMBL2880384 0.80 MEN1 (0.53) MEN1KMT2ATP53NLRP3RAB9A
SCHEMBL9464771 0.80 TP53 (0.49) MEN1KMT2ATP53NLRP3MAPT
SCHEMBL7261315 0.80 HSD17B10 (0.62) MEN1KMT2ATP53HSD17B10TSHR
SCHEMBL12940086 0.79 NLRP3 (0.48) MEN1KMT2ATP53NLRP3HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100022515-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2010-01-28 US disclosed
US-20100022515-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2010-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022515-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY GPR119, GCGR, GPR65 MEN1 3608/4885KMT2A 3065/4885TP53 4753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.